Suzhou, China

Liping Meng

This inventor holds 1 USPTO granted patent and 7 published patent applications and 1 EPO patent. Top assignee: Crystal Pharmaceutical (Suzhou) Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liping Meng. Retrieved from https://idiyas.com/inventor/liping-meng-3zhpjm9n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Liping Meng in Pharmaceutical Development.

Introduction

Liping Meng is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel drug formulations. His work focuses on improving treatment options for patients with specific medical conditions.

Latest Patents

Liping Meng holds 1 patent for his invention titled "Crystal form of Xevinapant for treating LA SCCHN." This patent presents novel crystalline forms of Xevinapant, along with preparation methods, pharmaceutical compositions containing these crystalline forms, and their uses in developing IAPs drugs and treatments for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).

Career Highlights

Liping Meng is associated with Crystal Pharmaceutical (Suzhou) Co., Ltd., where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing drug formulations that can significantly impact patient care.

Collaborations

Liping Meng collaborates with talented colleagues, including Jiale Qian and Chunxiang Huang, to further enhance the research and development efforts at their company.

Conclusion

Liping Meng's contributions to pharmaceutical innovations, particularly through his patent on Xevinapant, highlight his commitment to improving treatment options for patients. His work exemplifies the importance of research and collaboration in the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…